Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study

Scandinavian Journal of Gastroenterology

Volumn 43, Issue 12, 2008, Pages 1448-1455

  Storskrubb, Tom ^a,b,c   Aro, Pertti ^a   Ronkainen, Jukka ^a   Sipponen, Pentti ^c   Nyhlin, Henry ^d   Talley, Nicholas J ^e   Engstrand, Lars ^f   Stolte, Manfred ^g   Vieth, Michael ^g   Walker, Marjorie ^h   Agréus, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Kalix Hospital   (Sweden)

^c JORVI HOSPITAL   (Finland)

^d ERSTA HOSPITAL   (Sweden)

^e MAYO CLINIC   (United States)

^f SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^g INSTITUTE OF PATHOLOGY   (Germany)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Atrophic gastritis; Biological markers; Gastritis; Helicobacter pylori

Indexed keywords

GASTRIN 17; IMMUNOGLOBULIN G; PEPSINOGEN I; PEPSINOGEN II;

ADULT; ARTICLE; ATROPHIC GASTRITIS; BIOPSY TECHNIQUE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOSCOPY; ENZYME IMMUNOASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SEROLOGY; STOMACH ANTRUM;

ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; FEMALE; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 56749156460     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520802273025     Document Type: Article

References (40)

1. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249-59.
2. Plummer M, Buiatti E, Lopez G, Peraza S, Vivas J, Oliver W, et al. Histological diagnosis of precancerous lesions of the stomach: a reliability study. Int J Epidemiol 1997;26:716-20.
3. Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002;37:785-91.
4. Mårdh E, Mårdh S, Mårdh B, Borch K. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 2002;320:17-27.
5. Väänanen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91.
6. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990;50:4737-40.
7. Varis K, Taylor PR, Sipponen P, Samloff IM, Heinonen OP, Albanes D, et al. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol 1998;33:294-300.
8. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, et al. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol 2007;42 Suppl 17:21-7.
9. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 2007;23:1-10.
10. Sipponen P, Valle J, Varis K, Kekki M, Ihamaki T, Siurala M. Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990;25:513-9.
11. Varis K, Kekki M, Harkonen M, Sipponen P, Samloff IM. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol 1991; Suppl 186:117-23.
12. Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003;88:1239-47.
13. Knight T, Wyatt J, Wilson A, Greaves S, Newell D, Hengels K, et al. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. Br J Cancer 1996;73:819-24.
14. Varis K, Sipponen P, Laxen F, Samloff IM, Huttunen JK, Taylor PR, et al. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol 2000;35:950-6.
15. 13C-urea breath test, and serology. Scand J Gastroenterol 2000;35:138-41.
16. Karnes WE Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
17. Salomaa-Rasanen A, Kosunen TU, Mattila J, Sarna S, Rautelin H. Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis. Clin Diagn Lab Immunol 2004;11:1185-8.
18. Perri F, Ricciardi R, Merla A, Piepoli A, Gasperi V, Quitadamo M, et al. Appropriateness of urea breath test: a prospective observational study based on Maastricht 2000 guidelines. Aliment Pharmacol Ther 2002;16:1443-7.
19. Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS, et al. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol 2003;98:1005-9.
20. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Bloemena EC, Sandell M, Nelis GF, et al. Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels. Aliment Pharmacol Ther 1999;13:1343-6.
21. Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Fujioka T, et al. Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol 2003;38:937-41.
22. Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Harkonen M, Laxen F, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. Apmis 2003;111:619-24.
23. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE, et al. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol 2004;39:1280-8.
24. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care 1993;11:252-62.
25. Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, et al. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population. Scand J Gastroenterol 2005;40:302-11.
26. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993;34:1672-6.
27. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
28. Goetze JP, Paloheimo LI, Linnala A, Sipponen P, Hansen CP, Rehfeld JF. Gastrin-17 specific antibodies are too specific for gastrinoma diagnosis but stain G cells. Scand J Gastroenterol 2005;40:596-8.
29. Enroth H, Nyren O, Engstrand L. One stomach - one strain: does Helicobacter pylori strain variation influence disease outcome? Dig Dis Sci 1999;44:102-7.
30. Stolte M, Panayiotou S, Schmitz J. Can NSAID/ASA-induced erosions of the gastric mucosa be identified at histology? Pathol Res Pract 1999;195:137-42.
31. Dixon MF, Mapstone NP, Neville PM, Moayyedi P, Axon AT. Bile reflux gastritis and intestinal metaplasia at the cardia. Gut 2002;51:351-5.
32. Oberhuber G, Puspok A, Dejaco C, Hammer J, Zauner C, Pfeffel F, et al. Minimal chronic inactive gastritis: indicator of pre-existing Helicobacter pylori gastritis? Pathol Res Pract 1996;192:1016-21.
33. Miehlke S, Hackelsberger A, Meining A, Hatz R, Lehn N, Malfertheiner P, et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998;78:263-6.
34. Offerhaus GJ, Price AB, Haot J, ten Kate FJ, Sipponen P, Fiocca R, et al. Observer agreement on the grading of gastric atrophy. Histopathology 1999;34:320-5.
35. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
36. Aro P, Storskrubb T, Ronkainen J, Bolling-Sternevald E, Engstrand L, Vieth M, et al. Peptic ulcer disease in a general adult population - the Kalixanda study: a random population-based study. Am J Epidemiol 2006;163:1025-34.
37. Sipponen P, Laxen F, Huotari K, Harkonen M. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 2003;38:1209-16.
38. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-7.
39. Kitahara F, Shimazaki R, Sato T, Kojima Y, Morozumi A, Fujino MA. Severe atrophic gastritis with Helicobacter pylori infection and gastric cancer. Gastric Cancer 1998;1:118-24.
40. Agréus L, Engstrand L, Svärdsudd K, Nyrén O, Tibblin G. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. A population-based epidemiologic study. Scand J Gastroenterol 1995;30:752-7.